Stephanie Claire Bridgeman (Stephanie Bridgeman)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Epithelial Mesenchymal Transition

Transforming Growth Factor

Histone Deacetylase

Cardiovascular Disease

Top Venues

NPJ precision oncology

International journal of molecular sciences

Curtin University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Curtin University

Australia

PHD :: School of Pharmacy and Biomedical Science

Curtin University

Australia

MSC :: School of Biomedical Science

Publications

Xianning Lai, Sarah Kit Leng Lui, Hiu Yan Lam, Yuta Adachi, Wen Jing Sim, Natali Vasilevski, Nicola J Armstrong, Stephanie Claire Bridgeman, Nathan Michael Main, Tuan-Zea Tan, Janina E E Tirnitz-Parker, Jean-Paul Thiery, Hiromichi Ebi, Alan Prem Kumar, Pieter Johan Adam Eichhorn
SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition. NPJ precision oncology 7 (1) (2023)
Xianning Lai, Sarah Kit Leng Lui, Hiu Yan Lam, Yuta Adachi, Wen Jing Sim, Natali Vasilevski, Nicola J Armstrong, Stephanie Claire Bridgeman, Nathan Michael Main, Tuan-Zea Tan, Janina E E Tirnitz-Parker, Jean-Paul Thiery, Hiromichi Ebi, Alan Prem Kumar, Pieter Johan Adam Eichhorn
SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition. NPJ precision oncology 7 (1) (2023)
Stephanie Claire Bridgeman, Gaewyn Ellison, Philip Newsholme, Cyril Mamotte
The HDAC Inhibitor Butyrate Impairs β Cell Function and Activates the Disallowed Gene Hexokinase I. International journal of molecular sciences 22 (24) (2021)
Stephanie Claire Bridgeman, Wendy Northrop, Gaewyn Ellison, Thiru Sabapathy, Phillip E Melton, Philip Newsholme, Cyril D S Mamotte
Statins Do Not Directly Inhibit the Activity of Major Epigenetic Modifying Enzymes. Cancers 11 (4) (2019)